| Dr Marilu O'byrne, MD | |
|
1580 W Causeway Approach, Suite 3, Mandeville, LA 70471-3033 | |
| (985) 624-5573 | |
| (985) 624-9106 |
| Full Name | Dr Marilu O'byrne |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 43 Years |
| Location | 1580 W Causeway Approach, Mandeville, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083772453 | NPI | - | NPPES |
| 1318850 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 016256 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sterling Surgical Hospital | Slidell, LA | Hospital |
| Entity Name | Eye Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124071717 PECOS PAC ID: 0648205740 Enrollment ID: O20050928000006 |
News Archive
Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that it will delay the release of its financial results for the third quarter ended September 30, 2009, considering the restructuring process that the company is currently undergoing.
In acknowledgement of this year's World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take control, Medtronic, Inc. (NYSE: MDT) highlights the growing body of clinical evidence for Personal Continuous Glucose Monitoring (CGM) in improving glucose control for diabetes patients.
A new study points to the potential to use the remdesivir precursor, GS-441524, as a treatment choice for COVID-19.
› Verified 5 days ago
| Entity Name | Obyrne Eye Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649471335 PECOS PAC ID: 9335249937 Enrollment ID: O20070711000949 |
News Archive
Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that it will delay the release of its financial results for the third quarter ended September 30, 2009, considering the restructuring process that the company is currently undergoing.
In acknowledgement of this year's World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take control, Medtronic, Inc. (NYSE: MDT) highlights the growing body of clinical evidence for Personal Continuous Glucose Monitoring (CGM) in improving glucose control for diabetes patients.
A new study points to the potential to use the remdesivir precursor, GS-441524, as a treatment choice for COVID-19.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marilu O'byrne, MD 1580 W Causeway Approach, Suite 3, Mandeville, LA 70471-3033 Ph: (985) 624-5573 | Dr Marilu O'byrne, MD 1580 W Causeway Approach, Suite 3, Mandeville, LA 70471-3033 Ph: (985) 624-5573 |
News Archive
Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that it will delay the release of its financial results for the third quarter ended September 30, 2009, considering the restructuring process that the company is currently undergoing.
In acknowledgement of this year's World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take control, Medtronic, Inc. (NYSE: MDT) highlights the growing body of clinical evidence for Personal Continuous Glucose Monitoring (CGM) in improving glucose control for diabetes patients.
A new study points to the potential to use the remdesivir precursor, GS-441524, as a treatment choice for COVID-19.
› Verified 5 days ago
Dr. Natalie Colette Weil, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2623 Lakeshore Dr, Mandeville, LA 70448 Phone: 225-806-0109 | |
Dr. Edward Langlow, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 804 Heavens Dr, Suite 102, Mandeville, LA 70471 Phone: 985-792-1141 | |
Dr. Lauren Griffin, OD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3601 Highway 190, Mandeville, LA 70471 Phone: 985-624-3314 |